| __timestamp | Insmed Incorporated | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56292000 | 9804000 |
| Thursday, January 1, 2015 | 74277000 | 12796000 |
| Friday, January 1, 2016 | 122721000 | 15324000 |
| Sunday, January 1, 2017 | 109749000 | 13881000 |
| Monday, January 1, 2018 | 145283000 | 14820000 |
| Tuesday, January 1, 2019 | 131711000 | 14851000 |
| Wednesday, January 1, 2020 | 181157000 | 17204000 |
| Friday, January 1, 2021 | 272744000 | 29843000 |
| Saturday, January 1, 2022 | 397518000 | 40603000 |
| Sunday, January 1, 2023 | 571011000 | 57305000 |
Unleashing insights
In the competitive landscape of biotechnology, innovation is the key to success. Insmed Incorporated and Veracyte, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Insmed's R&D expenses surged by an impressive 914%, reaching a peak in 2023. In contrast, Veracyte's investment grew by 485% during the same period. This stark difference highlights Insmed's aggressive strategy to lead in innovation. By 2023, Insmed's R&D spending was nearly ten times that of Veracyte, showcasing its commitment to pioneering advancements in the biotech sector. As these companies continue to innovate, their R&D investments will likely play a crucial role in shaping the future of healthcare.
Amgen Inc. or Insmed Incorporated: Who Invests More in Innovation?
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Veracyte, Inc.
Research and Development: Comparing Key Metrics for Genmab A/S and Veracyte, Inc.
Research and Development Expenses Breakdown: Insmed Incorporated vs Blueprint Medicines Corporation
R&D Spending Showdown: Insmed Incorporated vs Pharming Group N.V.
Research and Development Investment: Insmed Incorporated vs Lantheus Holdings, Inc.
R&D Insights: How Insmed Incorporated and TG Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Insmed Incorporated and Viking Therapeutics, Inc.
R&D Spending Showdown: Insmed Incorporated vs BioCryst Pharmaceuticals, Inc.
R&D Insights: How Axsome Therapeutics, Inc. and Veracyte, Inc. Allocate Funds
R&D Insights: How TG Therapeutics, Inc. and Veracyte, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Veracyte, Inc.